SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-18-010103
Filing Date
2018-07-17
Accepted
2018-07-17 15:16:17
Documents
49
Period of Report
2018-02-28

Document Format Files

Seq Description Document Type Size
1 form10q.htm 10-Q 408658
2 ex31.htm EX-31 18666
3 ex32.htm EX-32 9881
4 image_001.jpg GRAPHIC 14774
  Complete submission text file 0001493152-18-010103.txt   2942609

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE FILE ptlf-20180228.xml EX-101.INS 473143
6 XBRL SCHEMA FILE ptlf-20180228.xsd EX-101.SCH 35037
7 XBRL CALCULATION FILE ptlf-20180228_cal.xml EX-101.CAL 38067
8 XBRL DEFINITION FILE ptlf-20180228_def.xml EX-101.DEF 140008
9 XBRL LABEL FILE ptlf-20180228_lab.xml EX-101.LAB 241325
10 XBRL PRESENTATION FILE ptlf-20180228_pre.xml EX-101.PRE 205726
Mailing Address 10120 SO. EASTERN AVENUE, SUITE 213, HENDERSON, NV 89052
Business Address 10120 SO. EASTERN AVENUE, SUITE 213, HENDERSON, NV 89052 (855) 682-7853
PetLife Pharmaceuticals, Inc. (Filer) CIK: 0001354591 (see all company filings)

IRS No.: 331133537 | State of Incorp.: NV | Fiscal Year End: 0831
Type: 10-Q | Act: 34 | File No.: 000-52445 | Film No.: 18956406
SIC: 2860 Industrial Organic Chemicals
Assistant Director 6